Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Heart Lung Transplant. 2021 May 30;40(11):1454–1462. doi: 10.1016/j.healun.2021.05.012

Table 3.

Association of Microbial Isolates and Histopathology With %ddcfDNA

Group n (%) %ddcfDNA p-value Subgroup comparison Subgroup p-value
Pathogen Type
  Respiratory Virus 20 (10.87) 0.99 (0.20, 1.89) 0.85 Respiratory Virus 0.57
  Bacteria 26 (14.13) 0.73 (0.48, 1.27) Bacterial
  Fungus 33 (17.93) 1.08 (0.33, 2.30) Fungus
  None 105 (57.07) 0.73 (0.33, 1.67)
Biopsy and Isolation
 Biopsy result Isolate
  Normal  Negative 62 (36.47) 0.74 (0.30, 1.67) 0.13 Normal Biopsy, Isolate Positive 0.05*
  Normal  Positive 55 (32.35) 0.66 (0.21, 1.48)
  Abnormal  Negative 27 (15.88) 1.03 (0.45, 1.90) Abnormal Biopsy, Isolate Positive
  Abnormal  Positive 26 (15.29) 1.23 (0.42, 2.64)
Biopsy, Rejection, and Isolation
 Abnormal biopsy Isolate
  Non-ACR/AMR  Negative 21 (12.35) 1.03 (0.45, 1.86) 0.98 Non-ACR/AMR Abnormal Biopsy, Isolate Positive 0.76
  Non-ACR/AMR  Positive 20 (11.76) 1.13 (0.49, 2.64)
  ACR/AMR  Negative 6 (3.53) 0.97 (0.62, 4.07) ACR/AMR, Isolate Positive
  ACR/AMR  Positive 8 (4.71) 1.77 (0.30, 3.27)

Data presented as number (percentage) for categorical variables, and as median (IQR) for continuous variables. Isolate positive, microbial isolate(s) other than normal flora were present in the BAL sample; Isolate negative, microbial isolates(s) other than normal flora not present in BAL; Abnormal biopsy, any abnormal histopathology finding; Non-ACR/AMR Abnormal biopsy, any abnormal histopathology finding other than ACR and without concurrent AMR; ACR/AMR, ACR as a biopsy finding and/or concurrent AMR; Subgroup comparison, categories included in subgroup Kruskal-Wallis or Mann-Whitney U tests.

*

Statistically significant (p<0.05)